# Parallel Bio **Entity class:** Company **Domain:** Organoid science / Drug discovery **Maturity:** Developed ## Definition Parallel Bio develops human immune-system models, including lymph-node organoids, for drug, vaccine, and toxicity testing. ## Mechanism and significance The broadcast uses the company as an example of human-relevant experimental systems that can outperform some animal models for particular translational questions. ## Relationships - **Research dossier:** [[research/ASI and RSI Timeline Research Moonshots|ASI and RSI Timeline Research Moonshots]] - **Ontology route:** [[ASI and RSI Timeline Ontology#Computational Biology and Virtual Cells|Computational Biology and Virtual Cells]] - **Primary fields:** [[AI-Driven Biology]] · [[Cellular Digital Twins]] · [[Computational Biology]] - **Adjacent concepts:** [[Patient-Derived Organoid]] · [[Animal-Free Toxicity Testing]] · [[Lila Sciences]] · [[Periodic Labs]] ## Sources and provenance - [[research/ASI and RSI Timeline Research Moonshots|ASI and RSI Timeline Research Moonshots]] — immediate source for this node's role in the broadcast research map. - [Parallel Bio](https://www.parallel.bio/press-release) — primary organizational or project source. ## Evidence boundary The research dossier establishes why this entity or concept belongs in the Moonshots ontology. Time-sensitive organizational, product, policy, and performance claims should be checked against the linked primary source or a current authoritative source before reuse as settled fact. ## Simple Reminders, Quotations, and Thoughts > Parallel Bio uses pluripotent stem cells to grow human lymph-node organoids and test drugs in parallel. The organoids are designed to replace some animal trials by predicting human drug response and toxicity more directly than experiments in mice. > **— Adapted from Richard Socher**, *MOONSHOTS Live, October 2026* [[reminders/Biotechnology/Human Organoids Can Outpredict Animal Trials by Richard Socher|Human Organoids Can Outpredict Animal Trials by Richard Socher]]